ZY · ZYMERGEN INC

Acquired Company

Ginkgo Bioworks completed its acquisition of Zymergen on October 19, 2022, with Zymergen stockholders receiving 0.9179 shares of Ginkgo Class A common stock for each Zymergen share.

Market Cap

N/A

52 Wk Range

N/A - N/A

Previous Close

$2.43

Open

$2.43

Volume

85

Day Range

$2.43 - $2.43

Enterprise Value

N/A

Cash

N/A

Avg Qtr Burn

N/A

Insider Ownership

N/A

Institutional Own.

N/A

Qtr Updated

N/A